Publications by authors named "Dean Wingerchuk"

Claim this Profile
C
Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder.
Alessandro Dinoto, Laura Cacciaguerra, Karl N Krecke, John Jing-Wei Chen, Dean M Wingerchuk

Neurol Neuroimmunol Neuroinflamm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Bruce A C Cree, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Dean M Wingerchuk

Lancet Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.
Edgar Carnero Contentti, Dean M Wingerchuk

Mult Scler· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral enhancement in MOG antibody-associated disease.
Paul Elsbernd, Laura Cacciaguerra, Karl N Krecke, John J Chen, David Gritsch, Dean M Wingerchuk

J Neurol Neurosurg Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in Aquaporin-4-IgG Serostatus in 986 Patients: A Laboratory-Based Longitudinal Analysis.
Masoud Majed, Cristina Valencia Sanchez, Jeffrey L Bennett, James Fryer, Martin D Mulligan, Dean M Wingerchuk

Ann Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Orhan Aktas, Hans-Peter Hartung, Michael A Smith, William A Rees, Kazuo Fujihara, Dean M Wingerchuk

J Neurol Neurosurg Psychiatry· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Brian G Weinshenker, Dean M Wingerchuk, Ari J Green, Jeffrey L Bennett, Ho Jin Kim

Mult Scler· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Disease Severity and Stability in NMOSD: A Global Clinical Record Review with Patient Interviews.
Marco Capobianco, Marius Ringelstein, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Dean M Wingerchuk

Neurol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Treatment Decisions in Neuromyelitis Optica Spectrum Disorder: A Global Clinical Record Review with Patient Interviews.
Ju-Hong Min, Marco Capobianco, Carly Welsh, Patricia Lobo, Gabrielle deFiebre, Dean M Wingerchuk

Neurol Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder.
Achim Berthele, Michael Levy, Dean M Wingerchuk, Sean J Pittock, Shulian Shang

Front Neurol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Intravenous Immunoglobulin Effective in Reducing the Risk of Mortality and Morbidity in Neuroinvasive West Nile Virus Infection?: A Critically Appraised Topic.
Amir A Mbonde, Marie F Grill, Ehab Y Harahsheh, Lisa A Marks, Dean M Wingerchuk

Neurologist· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
Jeffrey L Bennett, Orhan Aktas, William A Rees, Michael A Smith, Michele Gunsior, Dean Wingerchuk

EBioMedicine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder.
Dean M Wingerchuk, Brian G Weinshenker, Dana McCormick, Sasha Barron, Laura Simone

J Manag Care Spec Pharm· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Response to: Letter to the Editor Regarding "Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder".
Dean M Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston, Michael Levy

Neurol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Patients With Melanoma Brain Metastases, Is Combination Immune Checkpoint Inhibition a Safe and Effective First-Line Treatment? A Critically Appraised Topic.
David Gritsch, Maciej M Mrugala, Lisa A Marks, Dean M Wingerchuk, Cumara B O'Carroll

Neurologist· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD.
Shailee S Shah, Pearse Morris, Marina Buciuc, Deena Tajfirouz, Dean M Wingerchuk

Neurology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuromyelitis Optica Spectrum Disorder.
Dean M Wingerchuk, Claudia F Lucchinetti

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension.
Sean J Pittock, Kazuo Fujihara, Jacqueline Palace, Achim Berthele, Ho Jin Kim, Dean M Wingerchuk

Mult Scler· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder.
Dean M Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston, Michael Levy

Neurol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Patients With Functional Movement Disorders, Is Specialized Physical Therapy Effective in Improving Motor Symptoms?: A Critically Appraised Topic.
Marcus N Callister, Cynthia B Stonnington, Andrea Cuc, Sally B Alcott, Erika D Driver-Dunckley, Dean M Wingerchuk

Neurologist· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Romain Marignier, Sean J Pittock, Friedemann Paul, Ho Jin Kim, Jeffrey L Bennett, Dean M Wingerchuk

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders.
Vyanka Redenbaugh, Mayra Montalvo, Elia Sechi, Marina Buciuc, James P Fryer, Dean M Wingerchuk

Mult Scler J Exp Transl Clin· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
Hannah H Zhao-Fleming, Cristina Valencia Sanchez, Elia Sechi, Jery Inbarasu, Eelco F Wijdicks, Dean M Wingerchuk

Neurology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Autologous Stem Cell Transplantation a Safe and Effective Alternative to Whole Brain Radiation as Consolidation Therapy in Patients With Primary Central Nervous System Lymphoma?: A Critically Appraised Topic.
David Gritsch, Maciej M Mrugala, Lisa A Marks, Kartik Mangipudi, Matthew Neal, Dean M Wingerchuk

Neurologist· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Initiation of Fluoxetine Postacute Stroke Result in Improved Functional Recovery?: A Critically Appraised Topic.
Molly G Knox, Bart M Demaerschalk, Sally B Alcott, Lisa A Marks, Dean M Wingerchuk

Neurologist· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis